S. Peter Ludwig is a Senior Principal in the New York office of Fish & Richardson. Mr. Ludwig’s practice is focused on patent counseling, and portfolio management, patent prosecution, as well as litigation, licensing, and due diligence. Mr. Ludwig has companies and academic institutions in the life science, chemical and medical device fields. His experience includes work in the fields of biotechnology (vaccines, functional genomics, pharmacogenomics, high throughput screening, stem cell technology, gene therapy), pharmaceuticals (neuroleptic drugs, drug delivery systems, anti-metabolites, natural pharmaceuticals, anti-tumor agents, anti-viral agents), medical devices, photo-chemistry, paper chemistry, medical rubber products, aluminum processing and diagnostic products.
Mr. Ludwig has spoken on intellectual property issues for numerous professional associations, including the American Chemical Society, Pharmaceutical Research and Manufacturers of America, the New York Biotechnology Association, the Association of the Bar of the City of New York, the Biotechnology Industry Association, the Genetics Policy Institute, The American Conference Institute and the New York Intellectual Property Law Association.
Under an Ampart grant from the United States State Department, Mr. Ludwig lectured and advised government authorities and industry representatives in Brazil on strengthening intellectual property rights for biotechnology and pharmaceuticals.
From 2001 to 2005, Mr. Ludwig served as a speaker and as the chair or co-chair of the annual Biotechnology and Pharmaceutical Law and Business Program sponsored by the Practising Law Institute in New York and San Francisco. Mr. Ludwig was the Chair of the New York Intellectual Property Law Association’s Patentable Subject Matter Committee for the 2009-2010 term.
January 24th, 2018 | 11:30 am EST
2018 World Stem Cell Summit
December 7th, 2016 | 2:00 pm EST
2016 World Stem Cell Summit
December 10th, 2015 | 7:30 am EST
2015 World Stem Cell Summit
November 12th, 2015
IPR and Subject Matter Eligibility at the USPTO
August 12, 2015
"Process Patents Are Vital In Biotech — Why Not Extend Them?"
May 29th, 2013
NYBA 22nd Annual Meeting
December 3rd, 2012
World Stem Cell Summit 2012
April 27th, 2010 | 7:30 am EDT
World Research Group "Second Annual Corporate IP Counsel Summit"
January 2nd, 2011
What Israeli Companies Really Need To Know About IP Protection and Enforcement in the U.S.
October 3rd, 2011
2011 World Stem Cell Summit
September 12th, 2010 | 8:00 am EDT
Rodman & Renshaw Annual Global Investment Conference, 12th Annual Healthcare Conference
November 30th, 2011
13th Advanced Forum on Biotech Patents